OLA1 contributes to epithelial-mesenchymal transition in lung cancer by modulating the GSK3β/snail/E-cadherin...

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Obg-like ATPase 1 (OLA1) is a P-loop NTPase implicated in cellular regulation.
• Aberrant OLA1 expression is noted in various human cancers, but its specific role in cancer progression is unclear.
• Understanding OLA1's function is crucial for developing targeted lung cancer therapies.

Purpose of the Study:

• To investigate the role of OLA1 in lung cancer progression and its association with patient survival.
• To elucidate the molecular mechanisms by which OLA1 influences epithelial-mesenchymal transition (EMT).

Main Methods:

• Kaplan-Meier plotter analysis of OLA1 mRNA expression and overall survival in lung cancer patients.
• Immunohistochemical analysis of OLA1 protein levels in relation to tumor stage, metastasis, and EMT markers.
• In vitro studies involving OLA1 knockdown in lung adenocarcinoma cells to assess EMT and signaling pathway modulation.
• Co-immunoprecipitation assays to identify interactions between OLA1 and GSK3β.

Main Results:

• Increased OLA1 mRNA expression significantly correlates with shorter overall survival in lung cancer.
• Higher OLA1 protein levels are associated with advanced TNM stage and lymph node metastasis.
• OLA1 negatively correlates with E-cadherin expression and suppresses TGF-β-induced EMT.
• OLA1 interacts with GSK3β, inhibiting its activity via Ser9 phosphorylation and preventing Snail protein degradation, thereby promoting E-cadherin downregulation.

Conclusions:

• OLA1 promotes lung cancer progression by modulating the GSK3β/Snail/E-cadherin signaling pathway, driving EMT.
• OLA1 overexpression is a potential biomarker for poor prognosis in lung cancer patients.
• Targeting OLA1 may offer a novel therapeutic strategy for lung cancer treatment.